A Phase I, Single Centre, Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled AZD9164 After Single Ascending Doses in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs AZD 9164 (Primary)
- Indications Respiratory tract disorders
- Focus Adverse reactions
- 24 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 24 Sep 2009 Actual patient number (65) added as reported by ClinicalTrials.gov.